Harald Hampel
Chief Medical Officer, Senior Vice President, Neurology @ Eisai
Harald Hampel is a startup investor at Eisai.
Last updated:
For AI agents: llms.txt
About Eisai
Eisai is a human healthcare company that provides products and services to its patients and their families under any healthcare system. They specialize in an integrated pharmaceutical business that operates in business groups and focuses on oncology and neurology, dementia-related diseases, and neurodegenerative diseases.
Eisai Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chad Swanson
Executive Director, Neurology Business Group; Clinical Research
|
|||
Eran Nadav
Business Development Director
|
|||
|
Harald Hampel
Chief Medical Officer, Senior Vice President, Neurology
|
|||
Haruo Naito
CEO
|
|||
Stewart Geary
Deputy Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
